Welcome!

News Feed Item

arGEN-X Uses its Simple Antibody™ Platform to Identify Four 'Hotspots' on MET as Targets for its Therapeutic Antibody Program

BREDA, The Netherlands and GHENT, Belgium, April 7, 2014 /PRNewswire/ --

New findings to be presented at the American Association for Cancer Research annual meeting 

arGEN-X, a clinical stage human therapeutic antibody company, will present data on how its SIMPLE Antibody™ platform has identified four 'hotspots' on the MET protein that are suitable for therapeutic antibody targeting. Encoded by the oncogene c-Met, MET signalling is involved in cancer proliferation and metastasis and is activated by hepatocyte growth factor (HGF) in multiple cancers.

The new findings, resulting from a collaboration between arGEN-X scientists and the group of Professor Paolo Michieli at the Institute for Cancer Research and Treatment (Turin, Italy), will be presented by Dr. Anna Hultberg of arGEN-X on Tuesday 8 April in a Late-Breaking Mini-symposium at the American Association for Cancer Research (AACR) annual meeting in San Diego, CA, USA. Further details are given below.

Using its SIMPLE Antibody™ platform, arGEN-X selected 68 distinct antibodies that competed with HGF for MET binding. From this panel, antibodies recognizing four different regions or 'hotspots' for blockade of HGF-induced signalling on the known extracellular domains of MET were identified. These antibodies prevented metastatic spread in a triple-negative breast cancer model following neo-adjuvant therapy, and in a mutated KRAS colon cancer model as adjuvant therapy.

arGEN-X is targeting MET with ARGX-111, a SIMPLE Antibody™ based monoclonal antibody with differentiated product features, currently in a Phase Ib clinical trial.

According to Prof. Hans de Haard, Chief Scientific Officer of arGEN-X: "MET plays an important role in the signal transduction mechanisms responsible for cancer cell spread. Based on our understanding of the importance of certain MET epitopes in these mechanisms, we have created ARGX-111, a unique, MET-specific antibody with several modes of therapeutic action."

Details of the presentation are:

Four individually druggable MET hotspots mediate HGF-driven tumor progression 

  • Authors: Anna Hultberg, Cristina Basilico, Christophe Blanchetot, Natalie De Jonge, Valérie Hanssens, Gitte De Boeck, Alessia Mira, Manuela Cazzanti, Virginia Morello, Torsten Dreier, Michael Saunders, Hans De Haard, and Paolo Michieli 
  • Abstract #LBB-330, Late-Breaking Mini-symposium: Novel Drug Targets, Compounds, and Signatures of Response and Resistance
  • Tuesday, 8 April, 4.35-4.50pm (Pacific time), Room 8, San Diego Conference Center

About ARGX-111 

ARGX-111 is a human monoclonal antibody that blocks the known mechanisms of action of the cancer target MET, the product of the c-Met oncogene. ARGX-111 was discovered using the SIMPLE Antibody™ platform and has been equipped with NHance™ technology to optimize its pharmacokinetic half-life. Moreover, the antibody has been produced as a de-fucosylated antibody using POTELLIGENT® technology to boost Antibody Dependent Cellular Cytotoxicity (ADCC) and potentiate immune system destruction of MET-positive tumor cells. With this combination of unique attributes, ARGX-111 has demonstrated superior therapeutic potential in both solid and hematological MET-positive malignancies when compared to established biologic and small molecule inhibitors of the target.

A first-in-man Phase Ib study (NCT02055066) is recruiting patients with advanced MET over-expressing cancers that harbor circulating tumor cells (CTCs), from which metastases are known to arise.

POTELLIGENT® technology is licensed by BioWa Inc., a wholly-owned subsidiary of Kyowa Hakko Kirin Co. Ltd.

About arGEN-X  

arGEN-X is a clinical stage human therapeutic antibody company that is rapidly developing a product pipeline using its unique suite of antibody technologies. arGEN-X is creating first and best in class antibody therapeutics with highly differentiated target product profiles. Its therapeutic antibody programs, focused on cancer and autoimmune indications, are designed to deliver tangible benefits to patients with these diseases.

http://www.arGEN-X.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"Once customers get a year into their IoT deployments, they start to realize that they may have been shortsighted in the ways they built out their deployment and the key thing I see a lot of people looking at is - how can I take equipment data, pull it back in an IoT solution and show it in a dashboard," stated Dave McCarthy, Director of Products at Bsquare Corporation, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
Complete Internet of Things (IoT) embedded device security is not just about the device but involves the entire product’s identity, data and control integrity, and services traversing the cloud. A device can no longer be looked at as an island; it is a part of a system. In fact, given the cross-domain interactions enabled by IoT it could be a part of many systems. Also, depending on where the device is deployed, for example, in the office building versus a factory floor or oil field, security ha...
Amazon has gradually rolled out parts of its IoT offerings in the last year, but these are just the tip of the iceberg. In addition to optimizing their back-end AWS offerings, Amazon is laying the ground work to be a major force in IoT – especially in the connected home and office. Amazon is extending its reach by building on its dominant Cloud IoT platform, its Dash Button strategy, recently announced Replenishment Services, the Echo/Alexa voice recognition control platform, the 6-7 strategic...
"Qosmos has launched L7Viewer, a network traffic analysis tool, so it analyzes all the traffic between the virtual machine and the data center and the virtual machine and the external world," stated Sebastien Synold, Product Line Manager at Qosmos, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
"We are a leader in the market space called network visibility solutions - it enables monitoring tools and Big Data analysis to access the data and be able to see the performance," explained Shay Morag, VP of Sales and Marketing at Niagara Networks, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
@DevOpsSummit taking place June 6-8, 2017 at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @DevOpsSummit at Cloud Expo New York Call for Papers is now open.
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...